FMC Corporation has been experiencing a tumultuous period. They've declared a
quarterly dividend but are also facing extensive
restructuring, with
asset write-offs reaching around
$440M. Amid concerns over the decline in diamide sales, FMC's stock plummeted, with Barclays downgrading the stock to Underweight, and Credit also downgraded the corporation amid covenants arguments. Resulting, the stock has experienced a near 45% decrease. The company has launched a comprehensive
restructuring plan aiming at plant closures and Asia cost cuts. The plan, dubbed
Project Foundation, involves major restructuring charges and potential impairment. The stock has had a few ups and downs, even as a Board of Directors member bought up 7,000 shares. KeyBanc has been somewhat positive, raising the corporation's price target from $53 to $61, while maintaining an 'Overweight' rating. Nevertheless, there are persistent concerns over FMC's cash flow and valuation after the recent stock decline.
Fmc Corporation FMC News Analytics from Mon, 31 Mar 2025 07:00:00 GMT to Sat, 13 Dec 2025 20:03:04 GMT -
Rating -8
- Innovation -7
- Information 9
- Rumor 2
